Selected research
Industry Research
Prenatal Genetic Screening Services Industry Research Report 2026
Market perspective
The global Prenatal Genetic Screening Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Prenatal Genetic Screening Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Prenatal Genetic Screening Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Prenatal Genetic Screening Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Prenatal Genetic Screening Services include ACOG, Penn Medicine, Yale New Haven Health, Yale Medicine, PCRM Vancouver Fertility Clinic, Natera, VCGS, Genome Medical and Henry Ford Health, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Prenatal Genetic Screening Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Prenatal Genetic Screening Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Prenatal Genetic Screening Services Market by Company
ACOG
Penn Medicine
Yale New Haven Health
Yale Medicine
PCRM Vancouver Fertility Clinic
Natera
VCGS
Genome Medical
Henry Ford Health
Advocate Health Care
NJ Perinatal Associates
CENTOGENE
Lehigh Valley Health Network (LVHN)
Genetics.ie
Insight Medical Genetics
The Royal Women's Hospital
Stanford Medicine Children's Health
UCHealth
Atlantic Health System
Children's Hospital Colorado
Prenatal Genetic Screening Services Segment by Type
Prenatal Screening Tests
Prenatal Diagnostic Tests
Prenatal Genetic Screening Services Segment by Application
First-trimester
Second-trimester
Prenatal Genetic Screening Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prenatal Genetic Screening Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prenatal Genetic Screening Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prenatal Genetic Screening Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Prenatal Genetic Screening Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Prenatal Screening Tests
- Prenatal Diagnostic Tests
Applications
- First-trimester
- Second-trimester
Companies covered
- ACOG
- Penn Medicine
- Yale New Haven Health
- Yale Medicine
- PCRM Vancouver Fertility Clinic
- Natera
- VCGS
- Genome Medical
- Henry Ford Health
- Advocate Health Care
- NJ Perinatal Associates
- CENTOGENE
- Lehigh Valley Health Network (LVHN)
- Genetics.ie
- Insight Medical Genetics
- The Royal Women's Hospital
- Stanford Medicine Children's Health
- UCHealth
- Atlantic Health System
- Children's Hospital Colorado
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Prenatal Genetic Screening Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Prenatal Screening Tests
- 2.2.3 Prenatal Diagnostic Tests
- 2.3 Prenatal Genetic Screening Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 First-trimester
- 2.3.3 Second-trimester
- 2.4 Assumptions and Limitations
3 Prenatal Genetic Screening Services Breakdown Data by Type
- 3.1 Global Prenatal Genetic Screening Services Historic Market Size by Type (2021-2026)
- 3.2 Global Prenatal Genetic Screening Services Forecasted Market Size by Type (2027-2032)
4 Prenatal Genetic Screening Services Breakdown Data by Application
- 4.1 Global Prenatal Genetic Screening Services Historic Market Size by Application (2021-2026)
- 4.2 Global Prenatal Genetic Screening Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Prenatal Genetic Screening Services Market Perspective (2021-2032)
- 5.2 Global Prenatal Genetic Screening Services Growth Trends by Region
- 5.2.1 Global Prenatal Genetic Screening Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Prenatal Genetic Screening Services Historic Market Size by Region (2021-2026)
- 5.2.3 Prenatal Genetic Screening Services Forecasted Market Size by Region (2027-2032)
- 5.3 Prenatal Genetic Screening Services Market Dynamics
- 5.3.1 Prenatal Genetic Screening Services Industry Trends
- 5.3.2 Prenatal Genetic Screening Services Market Drivers
- 5.3.3 Prenatal Genetic Screening Services Market Challenges
- 5.3.4 Prenatal Genetic Screening Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Prenatal Genetic Screening Services Players by Revenue
- 6.1.1 Global Top Prenatal Genetic Screening Services Players by Revenue (2021-2026)
- 6.1.2 Global Prenatal Genetic Screening Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Prenatal Genetic Screening Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Prenatal Genetic Screening Services Head Office and Area Served
- 6.4 Global Prenatal Genetic Screening Services Players, Product Type & Application
- 6.5 Global Prenatal Genetic Screening Services Manufacturers Established Date
- 6.6 Global Prenatal Genetic Screening Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Prenatal Genetic Screening Services Market Size (2021-2032)
- 7.2 North America Prenatal Genetic Screening Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Prenatal Genetic Screening Services Market Size by Country (2021-2026)
- 7.4 North America Prenatal Genetic Screening Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Prenatal Genetic Screening Services Market Size (2021-2032)
- 8.2 Europe Prenatal Genetic Screening Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Prenatal Genetic Screening Services Market Size by Country (2021-2026)
- 8.4 Europe Prenatal Genetic Screening Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Prenatal Genetic Screening Services Market Size (2021-2032)
- 9.2 Asia-Pacific Prenatal Genetic Screening Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Prenatal Genetic Screening Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Prenatal Genetic Screening Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Prenatal Genetic Screening Services Market Size (2021-2032)
- 10.2 South America Prenatal Genetic Screening Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Prenatal Genetic Screening Services Market Size by Country (2021-2026)
- 10.4 South America Prenatal Genetic Screening Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Prenatal Genetic Screening Services Market Size (2021-2032)
- 11.2 Middle East & Africa Prenatal Genetic Screening Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Prenatal Genetic Screening Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Prenatal Genetic Screening Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 ACOG
- 12.1.1 ACOG Company Information
- 12.1.2 ACOG Business Overview
- 12.1.3 ACOG Revenue in Prenatal Genetic Screening Services Business (2021-2026)
- 12.1.4 ACOG Prenatal Genetic Screening Services Product Portfolio
- 12.1.5 ACOG Recent Developments
- 12.2 Penn Medicine
- 12.2.1 Penn Medicine Company Information
- 12.2.2 Penn Medicine Business Overview
- 12.2.3 Penn Medicine Revenue in Prenatal Genetic Screening Services Business (2021-2026)
- 12.2.4 Penn Medicine Prenatal Genetic Screening Services Product Portfolio
- 12.2.5 Penn Medicine Recent Developments
- 12.3 Yale New Haven Health
- 12.3.1 Yale New Haven Health Company Information
- 12.3.2 Yale New Haven Health Business Overview
- 12.3.3 Yale New Haven Health Revenue in Prenatal Genetic Screening Services Business (2021-2026)
- 12.3.4 Yale New Haven Health Prenatal Genetic Screening Services Product Portfolio
- 12.3.5 Yale New Haven Health Recent Developments
- 12.4 Yale Medicine
- 12.4.1 Yale Medicine Company Information
- 12.4.2 Yale Medicine Business Overview
- 12.4.3 Yale Medicine Revenue in Prenatal Genetic Screening Services Business (2021-2026)
- 12.4.4 Yale Medicine Prenatal Genetic Screening Services Product Portfolio
- 12.4.5 Yale Medicine Recent Developments
- 12.5 PCRM Vancouver Fertility Clinic
- 12.5.1 PCRM Vancouver Fertility Clinic Company Information
- 12.5.2 PCRM Vancouver Fertility Clinic Business Overview
- 12.5.3 PCRM Vancouver Fertility Clinic Revenue in Prenatal Genetic Screening Services Business (2021-2026)
- 12.5.4 PCRM Vancouver Fertility Clinic Prenatal Genetic Screening Services Product Portfolio
- 12.5.5 PCRM Vancouver Fertility Clinic Recent Developments
- 12.6 Natera
- 12.6.1 Natera Company Information
- 12.6.2 Natera Business Overview
- 12.6.3 Natera Revenue in Prenatal Genetic Screening Services Business (2021-2026)
- 12.6.4 Natera Prenatal Genetic Screening Services Product Portfolio
- 12.6.5 Natera Recent Developments
- 12.7 VCGS
- 12.7.1 VCGS Company Information
- 12.7.2 VCGS Business Overview
- 12.7.3 VCGS Revenue in Prenatal Genetic Screening Services Business (2021-2026)
- 12.7.4 VCGS Prenatal Genetic Screening Services Product Portfolio
- 12.7.5 VCGS Recent Developments
- 12.8 Genome Medical
- 12.8.1 Genome Medical Company Information
- 12.8.2 Genome Medical Business Overview
- 12.8.3 Genome Medical Revenue in Prenatal Genetic Screening Services Business (2021-2026)
- 12.8.4 Genome Medical Prenatal Genetic Screening Services Product Portfolio
- 12.8.5 Genome Medical Recent Developments
- 12.9 Henry Ford Health
- 12.9.1 Henry Ford Health Company Information
- 12.9.2 Henry Ford Health Business Overview
- 12.9.3 Henry Ford Health Revenue in Prenatal Genetic Screening Services Business (2021-2026)
- 12.9.4 Henry Ford Health Prenatal Genetic Screening Services Product Portfolio
- 12.9.5 Henry Ford Health Recent Developments
- 12.10 Advocate Health Care
- 12.10.1 Advocate Health Care Company Information
- 12.10.2 Advocate Health Care Business Overview
- 12.10.3 Advocate Health Care Revenue in Prenatal Genetic Screening Services Business (2021-2026)
- 12.10.4 Advocate Health Care Prenatal Genetic Screening Services Product Portfolio
- 12.10.5 Advocate Health Care Recent Developments
- 12.11 NJ Perinatal Associates
- 12.11.1 NJ Perinatal Associates Company Information
- 12.11.2 NJ Perinatal Associates Business Overview
- 12.11.3 NJ Perinatal Associates Revenue in Prenatal Genetic Screening Services Business (2021-2026)
- 12.11.4 NJ Perinatal Associates Prenatal Genetic Screening Services Product Portfolio
- 12.11.5 NJ Perinatal Associates Recent Developments
- 12.12 CENTOGENE
- 12.12.1 CENTOGENE Company Information
- 12.12.2 CENTOGENE Business Overview
- 12.12.3 CENTOGENE Revenue in Prenatal Genetic Screening Services Business (2021-2026)
- 12.12.4 CENTOGENE Prenatal Genetic Screening Services Product Portfolio
- 12.12.5 CENTOGENE Recent Developments
- 12.13 Lehigh Valley Health Network (LVHN)
- 12.13.1 Lehigh Valley Health Network (LVHN) Company Information
- 12.13.2 Lehigh Valley Health Network (LVHN) Business Overview
- 12.13.3 Lehigh Valley Health Network (LVHN) Revenue in Prenatal Genetic Screening Services Business (2021-2026)
- 12.13.4 Lehigh Valley Health Network (LVHN) Prenatal Genetic Screening Services Product Portfolio
- 12.13.5 Lehigh Valley Health Network (LVHN) Recent Developments
- 12.14 Genetics.ie
- 12.14.1 Genetics.ie Company Information
- 12.14.2 Genetics.ie Business Overview
- 12.14.3 Genetics.ie Revenue in Prenatal Genetic Screening Services Business (2021-2026)
- 12.14.4 Genetics.ie Prenatal Genetic Screening Services Product Portfolio
- 12.14.5 Genetics.ie Recent Developments
- 12.15 Insight Medical Genetics
- 12.15.1 Insight Medical Genetics Company Information
- 12.15.2 Insight Medical Genetics Business Overview
- 12.15.3 Insight Medical Genetics Revenue in Prenatal Genetic Screening Services Business (2021-2026)
- 12.15.4 Insight Medical Genetics Prenatal Genetic Screening Services Product Portfolio
- 12.15.5 Insight Medical Genetics Recent Developments
- 12.16 The Royal Women's Hospital
- 12.16.1 The Royal Women's Hospital Company Information
- 12.16.2 The Royal Women's Hospital Business Overview
- 12.16.3 The Royal Women's Hospital Revenue in Prenatal Genetic Screening Services Business (2021-2026)
- 12.16.4 The Royal Women's Hospital Prenatal Genetic Screening Services Product Portfolio
- 12.16.5 The Royal Women's Hospital Recent Developments
- 12.17 Stanford Medicine Children's Health
- 12.17.1 Stanford Medicine Children's Health Company Information
- 12.17.2 Stanford Medicine Children's Health Business Overview
- 12.17.3 Stanford Medicine Children's Health Revenue in Prenatal Genetic Screening Services Business (2021-2026)
- 12.17.4 Stanford Medicine Children's Health Prenatal Genetic Screening Services Product Portfolio
- 12.17.5 Stanford Medicine Children's Health Recent Developments
- 12.18 UCHealth
- 12.18.1 UCHealth Company Information
- 12.18.2 UCHealth Business Overview
- 12.18.3 UCHealth Revenue in Prenatal Genetic Screening Services Business (2021-2026)
- 12.18.4 UCHealth Prenatal Genetic Screening Services Product Portfolio
- 12.18.5 UCHealth Recent Developments
- 12.19 Atlantic Health System
- 12.19.1 Atlantic Health System Company Information
- 12.19.2 Atlantic Health System Business Overview
- 12.19.3 Atlantic Health System Revenue in Prenatal Genetic Screening Services Business (2021-2026)
- 12.19.4 Atlantic Health System Prenatal Genetic Screening Services Product Portfolio
- 12.19.5 Atlantic Health System Recent Developments
- 12.20 Children's Hospital Colorado
- 12.20.1 Children's Hospital Colorado Company Information
- 12.20.2 Children's Hospital Colorado Business Overview
- 12.20.3 Children's Hospital Colorado Revenue in Prenatal Genetic Screening Services Business (2021-2026)
- 12.20.4 Children's Hospital Colorado Prenatal Genetic Screening Services Product Portfolio
- 12.20.5 Children's Hospital Colorado Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst